Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial.
Park SH, Lim DH, Sohn TS, Lee J, Zang DY, Kim ST, Kang JH, Oh SY, Hwang IG, Ji JH, Shin DB, Yu JI, Kim KM, An JY, Choi MG, Lee JH, Kim S, Hong JY, Park JO, Park YS, Lim HY, Bae JM, Kang WK; ARTIST 2 investigators. Park SH, et al. Among authors: park ys, park jo. Ann Oncol. 2021 Mar;32(3):368-374. doi: 10.1016/j.annonc.2020.11.017. Epub 2020 Dec 3. Ann Oncol. 2021. PMID: 33278599 Free article. Clinical Trial.
A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
Kim NK, Park YS, Heo DS, Suh C, Kim SY, Park KC, Kang YK, Shin DB, Kim HT, Kim HJ, et al. Kim NK, et al. Among authors: park ys, park kc. Cancer. 1993 Jun 15;71(12):3813-8. doi: 10.1002/1097-0142(19930615)71:12<3813::aid-cncr2820711205>3.0.co;2-5. Cancer. 1993. PMID: 8508349 Clinical Trial.
A phase II study of VP-16-fosfamide-cisplatin combination chemotherapy plus early concurrent thoracic irradiation for previously untreated limited small cell lung cancer.
Woo IS, Park YS, Kwon SH, Park YL, Lee JA, Park MJ, Hyun IG, Jung KS, Bae HS, Oh DH, Kim WS, Park K, Park CH, Kim HJ, Ahn YC. Woo IS, et al. Among authors: park mj, park ys, park ch, park yl, park k. Jpn J Clin Oncol. 2000 Dec;30(12):542-6. doi: 10.1093/jjco/hyd135. Jpn J Clin Oncol. 2000. PMID: 11210163 Clinical Trial.
Spontaneous acute tumor lysis syndrome with advanced gastric cancer.
Woo IS, Kim JS, Park MJ, Lee MS, Cheon RW, Chang HM, Ahn JS, Lee JA, Park YI, Park YS, Shim JW, Yang I. Woo IS, et al. Among authors: park yi, park mj, park ys. J Korean Med Sci. 2001 Feb;16(1):115-8. doi: 10.3346/jkms.2001.16.1.115. J Korean Med Sci. 2001. PMID: 11289389 Free PMC article.
Clinical impacts of tumor cell contamination of hematopoietic stem cell products in metastatic breast cancer patients undergoing autologous peripheral blood stem cell transplantation: multicenter trial.
Ahn MJ, Noh YH, Lee YS, Lee YY, Choi IY, Kim IS, Joh EK, Shin DB, Kim SY, Cho KS, Kim HC, Kim HS, Suh CW, Kim SH, Lee JA, Park YS. Ahn MJ, et al. Among authors: park ys. J Korean Med Sci. 2001 Apr;16(2):175-82. doi: 10.3346/jkms.2001.16.2.175. J Korean Med Sci. 2001. PMID: 11306743 Free PMC article. Clinical Trial.
Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron.
Kang YK, Park YH, Ryoo BY, Bang YJ, Cho KS, Shin DB, Kim HC, Lee KH, Park YS, Lee KS, Heo DS, Kim SY, Cho EK, Lim HY, Kim WK, Lee JA, Kim TY, Lee JC, Yoon HJ, Kim NK. Kang YK, et al. Among authors: park yh, park ys. J Int Med Res. 2002 May-Jun;30(3):220-9. doi: 10.1177/147323000203000302. J Int Med Res. 2002. PMID: 12166338 Free article. Clinical Trial.
4,107 results